Today: 4 February 2026
Subscribe
Browse Category

NYSE:DOCS News 6 December 2025

Doximity (DOCS) Stock Hits New 52‑Week Low After Earnings Beat – Latest News, Forecasts and Outlook as of December 5, 2025

Doximity (DOCS) Stock Hits New 52‑Week Low After Earnings Beat – Latest News, Forecasts and Outlook as of December 5, 2025

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, saw its shares plunge to a new 52‑week low on Friday, December 5, 2025, despite having recently delivered another quarter of double‑digit growth and earnings beats. Doximity This article pulls together the latest publicly available news, analyst forecasts and institutional moves through December 5, 2025, to give a…
6 December 2025
·····
Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets

U.S. stocks ended Friday modestly higher, but under the surface December 5, 2025 was a rough day for a cluster of high‑beta tech, Brazilian financials, streaming, and crypto‑linked names. The S&P 500 closed around 6,870 points (+0.19%), the Dow Jones Industrial Average added 0.22%, and the Nasdaq Composite rose 0.43%, even as Bitcoin slipped roughly 3% to just under $89,300.  Nasdaq Yet individual stocks saw double‑digit…
6 December 2025
·············

Stock Market Today

  • LSEG Shares Plunge Amid AI Disruption Fears and IPO Drought
    February 4, 2026, 3:10 AM EST. The London Stock Exchange Group (LSEG) shares plunged over 40% from February 2025 highs, hitting 7,180p-the lowest since March 2023. Investors fret over AI-driven disruptions from firms like Anthropic simplifying legal workflows, potentially affecting LSEG's core data business. Ongoing IPO inactivity in London further dampens sentiment, despite potential listings from fintech companies such as Monzo and Revolut. Despite the selloff, LSEG reported solid Q3 revenue growth in data, analytics, and risk intelligence, with management maintaining optimistic guidance of 6.5-7.5% organic income growth and EBITDA increases. Technical analysis signals further downside risk, as shares breach key support and approach a bearish 'death cross' pattern, suggesting continued pressure on the stock price.
Go toTop